| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $204K | — |
| Cost of Revenue | $617K | — |
| Gross Profit | -$413K | — |
| R&D Expense | $199K | -92.0% |
| SG&A Expense | $16.1M | +218.7% |
| Operating Income | -$269.7M | -2701.9% |
| Pre-tax Income | -$270.3M | -2798.7% |
| Net Income | -$282.5M | -2938.9% |
| EPS (Basic) | -$11.16 | -50.8% |
| EPS (Diluted) | -$11.16 | -50.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $10.4M | +1101.6% |
| Inventory | $645K | -65.5% |
| Current Assets | $18.9M | +494.9% |
| Total Assets | $269.1M | +3579.0% |
| Current Liabilities | $4.7M | -9.5% |
| Total Liabilities | $4.7M | -11.7% |
| Stockholders' Equity | $264.4M | — |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$11.0M | -58.6% |
| Investing Cash Flow | -$187.5M | — |
| Financing Cash Flow | $215.5M | +3548.1% |